Tumor Angiogenesis: A Quantitative Method for Histologic Grading 2
The DOI matches its Crossref record.
Abstract
A quantitative technique for measuring the degree of angiogenesis in tumors is described. The microscopic angiogenesis grading system was based on 3 parameters of endothelial regeneration: vasopro-liferation, endothelial cell hyperplasia, and endothelial cytology, providing a composite rating of 0–100. The method was tested in grading the degree of neovascularization in cerebral neoplasms and vascular tissues induced by tumors and tumor extracts; it appeared to give quantitatively reproducible and biologically reasonable results. Preliminary observations on a variety of other tumors suggest that solid neoplasms can be classified according to the extent of angiogenesis along a spectrum ranging from the “endothelial-poor” tumors, such as the chondrosarcomas, to the “endothelial-rich” tumors, such as glioblastomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Clinical translation of angiogenesis inhibitors
Kerbel, R., & Folkman, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc905 · Cited by 1,517
Hlatky, L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.883 · Cited by 787
Weidner, N. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666038 · Cited by 718
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
Cohen, M. H., Shen, Y. L., Keegan, P., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0121 · Cited by 655
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., & Semenza, G. L. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2606::aid-cncr25>3.0.co;2-w · Cited by 604
Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging
Knopp, E. A., Cha, S., Johnson, G., Mazumdar, A., Golfinos, J. G., Zagzag, D., Miller, D. C., Kelly, P. J., & Kricheff, I. I. (1999) · Radiology · doi:10.1148/radiology.211.3.r99jn46791 · Cited by 596
Stratmann, A., Risau, W., & Plate, K. H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65733-1 · Cited by 485
Microvessel density is a prognostic indicator for patients with astroglial brain tumors
Leon, S. P., Folkerth, R. D., & Black, P. M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<362::aid-cncr20>3.0.co;2-z · Cited by 481
Mechanisms of Glioma-Associated Neovascularization
Hardee, M. E., & Zagzag, D. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.06.030 · Cited by 475
miR-296 Regulates Growth Factor Receptor Overexpression in Angiogenic Endothelial Cells
Würdinger, T., Tannous, B. A., Saydam, O., Skog, J., Grau, S., Soutschek, J., Weissleder, R., Breakefield, X. O., & Krichevsky, A. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.005 · Cited by 463
Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas
Fine, H. A., Figg, W. D., Jaeckle, K., Wen, P. Y., Kyritsis, A. P., Loeffler, J. S., Levin, V. A., Black, P. M., Kaplan, R., Pluda, J. M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.708 · Cited by 423
Redefining the Target: Chemotherapeutics as Antiangiogenics
Miller, K. D., Sweeney, C. J., & Sledge, G. W. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1195 · Cited by 395
Quantitative angiogenesis assays: Progress and problems
Jain, R. K., Schlenger, K., Hockel, M., & Yuan, F. (1997) · Nature Medicine · doi:10.1038/nm1197-1203 · Cited by 385
Inhibition of tumor angiogenesis mediated by cartilage.
Brem, H., & Folkman, J. (1975) · The Journal of experimental medicine · doi:10.1084/jem.141.2.427 · Cited by 359
Angiogenesis in Gliomas: Biology and Molecular Pathophysiology
Fischer, I., Gagner, J., Law, M., Newcomb, E. W., & Zagzag, D. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00115.x · Cited by 350
Cheng, S. Y., Huang, H. J., Nagane, M., Ji, X. D., Wang, D., Shih, C. C., Arap, W., Huang, C. M., & Cavenee, W. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8502 · Cited by 342
Angiogenesis in malignant gliomas
Plate, K. H., & Risau, W. (1995) · Glia · doi:10.1002/glia.440150313 · Cited by 337
Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H.-J., de Tribolet, N., & Cavenee, W. K. (1994) · Nature Genetics · doi:10.1038/ng1094-171 · Cited by 307
Susceptibility contrast imaging of cerebral blood volume: Human experience
Rosen, B. R., Belliveau, J. W., Aronen, H. J., Kennedy, D., Buchbinder, B. R., Fischman, A., Gruber, M., Glas, J., Weisskoff, R. M., Cohen, M. S., et al. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910220227 · Cited by 300
The role of hyaluronan in tumour neovascularization (review)
Rooney, P., Kumar, S., Ponting, J., & Wang, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600511 · Cited by 271
Angiogenesis and invasion in glioma
Onishi, M., Ichikawa, T., Kurozumi, K., & Date, I. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-010-0007-z · Cited by 264
Desbaillets, I., Diserens, A.-C., Tribolet, N. D., Hamou, M.-F., & Meir, E. G. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1201 · Cited by 243
“Maximal vessel density is reached in glioblastoma which is among the most vascularized tumors (4).”
BackgroundPTEN controls tumor-induced angiogenesis
Wen, S., Stolarov, J., Myers, M. P., Su, J. D., Wigler, M. H., Tonks, N. K., & Durden, D. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081063798 · Cited by 241
Cheng, S.-Y., Nagane, M., Huang, H.-J. S., & Cavenee, W. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12081 · Cited by 224
Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Tseng, S.-H., Lin, S.-M., Chen, J.-C., Su, Y.-H., Huang, H.-Y., Chen, C.-K., Lin, P.-Y., & Chen, Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0105 · Cited by 217
The Role of the Vascular Phase in Solid Tumor Growth: A Historical Review
Ribatti, D., Vacca, A., & Dammacco, F. (1999) · Neoplasia · doi:10.1038/sj.neo.7900038 · Cited by 173
MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3
Zheng, X., Chopp, M., Lu, Y., Buller, B., & Jiang, F. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.10.026 · Cited by 168
“Glioma blood vessels show endothelial cell proliferation which is a key feature of high grade gliomas in the WHO grading system [5; 6; 7].”
Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis
Raza, S. M., Lang, F. F., Aggarwal, B. B., Fuller, G. N., Wildrick, D. M., & Sawaya, R. (2002) · Neurosurgery · doi:10.1097/00006123-200207000-00002 · Cited by 167
Metadata
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1972-02
- Volume
- 48
- Issue
- 2
- Pages
- 347-56
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W1917703525
- Cited by
- 414
- References
- 0
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.